DIGITAL-COOPERATION
27.5.2024 20:23:30 CEST | Business Wire | Press release
The Digital Cooperation Organization (DCO), a global multilateral organization committed to enabling digital prosperity for all by accelerating the sustainable and inclusive growth of the digital economy, announced the launch of EconomiX magazine, a publication offering insights from international digital economy thought leaders into ways nations and organizations can seize the digital economy’s opportunities to spur digital transformation globally. By merging insights from different stakeholders from the public and private sectors, academia, and international organizations from DCO Member States and other countries, EconomiX provides a holistic view of the digital economy from different perspectives.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527424476/en/
1st Issue of the “EconomiX by the DCO” magazine (Graphic: AETOSWire)
The first edition of EconomiX covers a wide range of topics including global news on the digital economy, updates from DCO Member States, special articles on "Developing new AI business models" and "Digital upskilling -future-proof jobs". The theme of the magazine's first issue "Growth Unleashed - AI: Powering Economic Prosperity" delves into the world of artificial intelligence and its transformative impact on economies worldwide.
In addition to exclusive interviews with H.E. Dr. Bosun Tijani, Minister of Communications, Innovation and Digital Economy of the Federal Republic of Nigeria, and H.E. Paula Ingabire, Minister of Information and Communications Technology and Innovation of the Republic of Rwanda, and Ms. Deemah AlYahya, Secretary-General of the DCO, this issue features articles and interviews with a distinguished group of ministers, CEOs, and experts in technology and the digital economy.
Manel Bondi, DCO’s Chief of Digital Markets Growth, commented: "EconomiX stands as a catalyst for change and empowerment amidst the digital revolution. It fills an important gap with its focus on the economic dimension of technology as a key pillar to drive and sustain inclusive and meaningful economic growth across the globe. It demonstrates how communities, businesses, and governments can cooperate meaningfully and pave the way toward achieving digital prosperity for all. EconomiX is a platform that fosters knowledge sharing, innovation, and inspiration for our readers, and reflects our dedication to promoting cooperation to develop the global digital economy."
Addressing critical aspects of digital economic advancement like policy making, data transformation, digital updates, women empowerment, and thought leadership, EconomiX endeavors to guide its readers through the digital revolution. It aims to provide actionable insights, expert analysis, and case studies for navigating digital change, fostering an understanding of how to leverage digital transformation for economic and social prosperity.
The magazine is a vital tool for digital transformation, aimed at empowering change by fostering knowledge exchange, enhancing cooperation, uplifting social prosperity, and stimulating innovation. It presents global trends and innovations, advocates for inclusive digital transformation, and fosters a community of leaders shaping the digital future. It also highlights the DCO's impactful initiatives and showcases success stories from the network. Available in both digital and print formats, it is an invaluable resource for those committed to making a significant impact in the digital realm. https://www.dco.org/economix
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240527424476/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom